Is This Stock At Support? Tue, Feb 6, 2018

BMRN $102.19 -1.42 (-1.37%)

BioMarin Pharmaceutical Inc

Stock Charts Stock Price Earnings Industry Stocks Company Profile

BioMarin Stock Charts

The 5 year and 1 year stock charts are below.

BioMarin 5 year stock chart
BioMarin 5 year stock chart

50 Day Moving Average

The 50 Day Moving Average is at $92.75 which is 10.18% below the stock price of $102.19.

200 Day Moving Average

The 200 Day Moving Average is at 87.47 which is 16.83% below the stock price of $102.19.

BMRN Stock Price

Below are a few key dates for the stock price.

Year To Date


The most recent stock price is $102.19.

The Year To Date (YTD) return is +12.26%.

52 Week Low


The 52 Week Low stock price is $75.81 set on Fri, Apr 6, 2018 which is 101 days ago.

The current price per share is 34.80% above the 52 week low.

52 Week High


The 52 Week High stock price is $104.00 set on Mon, Jul 16, 2018 which is Today. View all of today's 52 week highs.

The current price per share is -1.74% below the 52 week high.

All Time High

Jul 2015

The All Time High stock price is $151.75 set on Mon, Jul 20, 2015 which is 1,092 days ago.

The current price per share is -32.66% below the all time high.


Below is the EPS, P/E Ratio and Earnings Date.

The EPS is -$0.84 and the P/E Ratio is 0.

Earnings Dates

Stocks can make big percentage moves on the earnings announcement.

Companies announce earnings either before the market open or after the close.


The Earnings Release Date for BioMarin Pharmaceutical Inc was Thu, Feb 22, 2018.

Since this earnings release 144 days ago, the stock price is up by +21.35%.


The most recent Earnings Release Date was on Wed, Apr 25, 2018, which was 82 days ago.

Since this earnings date, the stock price is up by +25.96%.

BioMarin Dividend

Below is important Dividend information.

BMRN currently does not pay a dividend.

You may like this list of best dividend stocks of 2018.

Biotech & Pharma Industry

Below are other stocks in the same industry as BioMarin.

BMRN Company Profile

Learn more about BioMarin.

BioMarin Pharmaceutical Inc is a Health Care stock that trades on the NASDAQ and has a market capitalization of $18.31 Billion.

http://www.biomarinpharm.comBioMarin Pharmaceutical Inc. is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the Company's therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates. Its commercial products include Aldurazyme (laronidase) for Mucopolysaccharidosis I (MPS I), Firdapse (amifampridine phosphate) for Lambert Eaton Myasthenic Syndrome (LEMS), Kuvan (sapropterin dihydrochloride) for phenylketonuria (PKU), Naglazyme (galsulfase) for Mucopolysaccharidosis VI (MPS VI) and Vimizim (elosulfase alpha) for Mucopolysaccharidosis IV Type A (MPS IV A). The Company is conducting clinical trials on various product candidates for the treatment of various diseases. Its clinical product candidates include Brineura, pegvaliase, vosoritide, BMN 270 and BMN 250.

Spend a few minutes browsing the BioMarin Pharmaceutical Inc, web site at

For more information and analysis of BMRN, visit Bloomberg, Google Finance, Nasdaq, Yahoo Finance.